Every so often, a fundus exam turns up something visually unmistakable — dozens of tiny, glittering yellow-white specks scattered across the retinal surface, as though someone had sprinkled fine glass shards across it. This is Bietti’s Crystalline Dystrophy, a rare, slow-developing condition documented more heavily in East Asian populations in published research, though certainly not restricted to them. In Rwanda, most patients are first flagged when a local ophthalmologist notices this crystal pattern while examining the eye for something else entirely.
One thing worth clarifying early: the crystals aren’t the actual cause of vision loss — they’re better thought of as a visible clue pointing to what’s happening underneath. The real determinant of how vision holds up is the condition of the retinal tissue around those deposits, and that’s where we concentrate our evaluation.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
”
Not by themselves — they’re a marker of the disease rather than its actual cause. It’s the surrounding thinning of the retina and choroid that drives vision loss, and that’s what our follow-up visits are set up to track.”
”
Usually quite slowly, spread across many years or even decades, though how quickly it moves varies from patient to patient. That variability is a key reason we lean toward regular check-ins rather than a one-off exam.”
“The medical literature notes a higher frequency in East Asian populations, but it’s by no means limited to any single group — we do see it, including among patients from Rwanda and elsewhere in the region.”
“The presence of crystalline deposits on examination, backed up by a positive CYP4V2 genetic test, is what separates Bietti’s Crystalline Dystrophy from other rod-cone conditions that could otherwise look quite alike at a glance.”
